Gain Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.714; its P/E ratio is -1.86; Gain Therapeutics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	$ 55.18K	-
Gross Profit	-	-	-	$ 55.18K	-
EBIT	$ -4.82M	$ -4.80M	$ -7.79M	$ -5.27M	$ -4.76M
EBITDA	$ -4.79M	$ -4.78M	$ -7.77M	$ -5.25M	$ -4.74M
Net Income Common Stockholders	$ -4.72M	$ -4.72M	$ -7.69M	$ -5.14M	$ -4.67M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 16.79M	$ 12.23M	$ 16.19M	$ 17.82M	$ 20.14M
Total Assets	$ 18.61M	$ 14.10M	$ 18.26M	$ 21.18M	$ 24.10M
Total Debt	$ 1.03M	$ 1.04M	$ 1.14M	$ 1.21M	$ 1.27M
Net Debt	$ -15.77M	$ -11.19M	$ -15.05M	$ -16.61M	$ -18.86M
Total Liabilities	$ 6.03M	$ 6.77M	$ 7.14M	$ 6.17M	$ 5.22M
Stockholders Equity	$ 12.58M	$ 7.33M	$ 11.09M	$ 15.14M	$ 18.88M
Cash Flow	-
Free Cash Flow	$ -5.66M	$ -3.97M	$ -5.03M	$ -4.23M	$ -3.91M
Operating Cash Flow	$ -5.66M	$ -3.97M	$ -5.02M	$ -4.22M	$ -3.90M
Investing Cash Flow	$ 3.14M	$ 1.93M	$ 3.05M	$ 2.11M	$ 133.83K
Financing Cash Flow	$ 9.56M	$ 134.47K	$ 2.20M	$ 748.91K	$ -21.58K

Currency in USD

Gain Therapeutics Earnings and Revenue History

Income Statement >

Gain Therapeutics Debt to Assets

Balance Sheet >

Gain Therapeutics Cash Flow

Cash Flow >

Gain Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing